Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus

Acta Diabetologica

Volumn 47, Issue 3, 2010, Pages 243-250

  Sobel, Douglas O ^a   Henzke, Annette ^a   Abbassi, Val ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Combination therapy; Cyclosporin; Methotrexate; Treatment; Type 1 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; CARBON DIOXIDE; CREATININE; CYCLOSPORIN A; ELECTROLYTE; HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; INSULIN DERIVATIVE; METHOTREXATE; NITROGEN; UREA; URIC ACID;

ABNORMAL LABORATORY RESULT; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CARBON DIOXIDE BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROLYTE BLOOD LEVEL; FEMALE; GINGIVA HYPERTROPHY; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERTRICHOSIS; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE; LEUKOCYTE COUNT; LOW DRUG DOSE; LYMPHOCYTE COUNT; MALE; MUCOSA INFLAMMATION; PILOT STUDY; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CYCLOSPORINE; DIABETES MELLITUS, TYPE 1; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; MALE; METHOTREXATE; PILOT PROJECTS; REMISSION INDUCTION;

EID: 77955653658     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0188-2     Document Type: Article

References (44)

1. SL Rabinowe GS Eisenbarth 1984 Type I diabetes mellitus: a chronic autoimmune disease? Pediatr Clin North Am 31 531 543 1:STN:280: DyaL2c3itFSksA%3D%3D 6203091
2. L Machnica A Osior P Jarosz-Chobot G Deja J Polanska E Otto-Buczkowska 2008 An analysis of the prevalence of thyroid autoantibodies:thyroid peroxidase and thyroglobulin antibodies in children with newly diagnosed diabetes mellitus type 1 during 20000-2004 in Upper Silesia region, Poland Acta Diabetol 45 37 40 10.1007/s00592-007-0017-4 1:CAS:528:DC%2BD1cXhs1yksrs%3D 17932620 (Pubitemid 351238274)
3. RB Elliott JR Crossley CC Berryman AG James 1981 Partial preservation of pancreatic beta-cell function in children with diabetes Lancet 2 1 4 10.1016/S0140-6736(81)90249-X 1:CAS:528:DyaL3MXmtFGlsLo%3D 6113394
4. LC Harrison PG Colman B Dean R Baxter FIR Martin 1985 Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine Diabetes 34 1306 1308 10.2337/diabetes.34.12.1306 1:STN:280:DyaL28%2Fls1Kisg%3D%3D 3905463
5. J Ludvigsson L Heding G Liedén B Marner A Lernmark 1983 Plasmapharesis in the initial treatment of insulin-dependent diabetes mellitus in children Br Med J 286 176 178 10.1136/bmj.286.6360.176 1:STN:280: DyaL3s7gt1aiuw%3D%3D
6. RA Jackson MA Morris BF Haynes GS Eise nbarth 1974 Increased circulating Ia antigen-bearing T cells in type 1 diabetes mellitus N Engl Med 306 785 788
7. AS Al-Kassab S Raziuddin 1990 Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type 1 diabetes mellitus Clin Exp Imunol 81 267 271 1:STN:280:DyaK3czlt1yltA%3D%3D
8. BO Roep 2003 The role of T cells in the pathogenesis of type 1 diabetes from cause to cure Diabetologia 46 305 321 1:CAS:528:DC%2BD3sXksVWjtL4%3D 12687328
9. B Keymeulen E Vandemeulebroucke A Zieler, et al. 2005 Insulin needs after CD3-antibody therapy in New-Onset Type 1 diabetes New Eng J Med 352 2598 2608 10.1056/NEJMoa043980 1:CAS:528:DC%2BD2MXls1Wqu7k%3D 15972866 (Pubitemid 41007846)
10. KC Herold W Hagopian JA Auger, et al. 2002 Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus N Engl J Med 346 1692 1698 10.1056/NEJMoa012864 1:CAS:528:DC%2BD38XktVansLY%3D 12037148 (Pubitemid 34547482)
11. GA Hollander BE Bierer SJ Burakoff 1994 Molecular and biological actions of cyclosporin A and FK506 on T cell development and function Transfus Sci 15 207 220 10.1016/0955-3886(94)90133-3 1:STN:280:DyaK28%2FotlSltw%3D%3D 10155542 (Pubitemid 24267835)
12. A Laupacis C Gardell J Dupre, et al. 1983 Cyclosporin prevents diabetes in BB Wistar rats Lancet 1 8314 8315
13. Y Mori M Suko H Okudaira, et al. 1986 Preventive effects of cyclosporin on diabetes in NOD mice Diabetologia 29 244 247 10.1007/BF00454884 1:CAS:528:DyaL28XktlGhu7c%3D 3519340
14. CR Stiller J Dupré M Gent MR Jenner PA Keown A Laupacis R Martell NW Rodger BV Graffenried BMJ Wolfe 1984 Effects of cyclosporin immunosuppression in insulin-dependent diabetes mellitus of recent onset Science 223 1362 1367 10.1126/science.6367043 1:STN:280:DyaL2c7ks1OltA%3D%3D 6367043
15. R Assan M Debray-Sachs C Laborie L Chatenoud G Feutren MC Quiniou-Debrie G Thomas JF Bach 1985 Metabolic and immunologic effects of cyclosporin in recently diagnosed type 1 diabetes mellitus Lancet 1 67 71 10.1016/S0140- 6736(85)91964-6 1:STN:280:DyaL2M%2FosFWnug%3D%3D 2857024
16. The Canadian-European Randomized Control Trial Group 1988 Cyclosporin-induced remission of IDDM after early intervention. Association of 1 year of cyclosporin treatment with enhanced insulin secretion Diabetes 37 1575 1582
17. C Graeb H Arbogast M Guba KW Jauch W Land 2004 Cyclosporine: 20 years of experience at the University of Munich Transplant Proc 36 2 suppl 125S 129S 10.1016/j.transproceed.2004.01.046 1:CAS:528:DC%2BD2cXisVelsL0%3D 15041321 (Pubitemid 38373845)
18. D Cattaneo N Perico F Gaspari G Remuzzi 2004 Nephrotoxic aspects of cyclosporine Transplant Proc 36 234S 239S 10.1016/j.transproceed.2004.01.011 1:CAS:528:DC%2BD2cXisVeltrg%3D 15041344 (Pubitemid 38373868)
19. ME Weinblatt 1985 Toxicity of low dose methotrexate in rheumatoid arthritis J Rheumatol 12 Suppl 2 35 39
20. F Aydin T Canturk AY Turanli 2006 Methotrexate and cyclosporin combination for the treatment of severe psoriasis Clin Exp Dermatol 31 520 524 10.1111/j.1365-2230.2006.02153.x 1:STN:280:DC%2BD283oslSmtA%3D%3D 16716153 (Pubitemid 43806583)
21. ML Sorror W Leisenring HJ Deeg PJ Martin R Storb 2005 Twenty-year follow-up in patients with aplastic anemia given marrow rafts from HLA-identical siblings and randomized to received methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease (letter) Biol Blood Marrow Transplant 11 567 568 10.1016/j.bbmt.2005.03.004 15983557 (Pubitemid 40862454)
22. P Tugwell T Pincus D Yocum, et al. 1995 Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. Methotrexate-cyclosporin combination study group N Engl J Med 33 137 141 10.1056/NEJM199507203330301
23. J Berth-Jones 2005 The use of ciclosporin in psoriasis J Dermatolog Treat 16 258 277 10.1080/09546630500423914 1:CAS:528:DC%2BD28Xmtl2jsQ%3D%3D 16428145 (Pubitemid 43170195)
24. SE Walker SK Ranatunga 2006 Rheumatoid arthritis: a review Mo Med 103 539 544 17133760
25. EH Giannini EJ Brewer N Kuzmina A Shaikov A Maximov I Vorontsov CW Fink AJ Newman JT Cassidy LS Zemel 1992 Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The pediatric rheumatology collaborative study group and the cooperative children's study group N Engl Med 326 1043 1049 1:STN:280:DyaK387psFemuw%3D%3D
26. L Naldi CE Griffiths 2005 Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefit and risks Br J Dermatol 152 597 615 10.1111/j.1365-2133.2005.06563.x 1:CAS:528:DC%2BD2MXksFymsro%3D 15840088 (Pubitemid 40571289)
27. P-F Bougneres P Landais C Boisson J-C Carel N Frament C Boitard J-L Chaussain J-F Bach 1990 Limited duration of remission of insulin dependency in children with recent overt type 1 diabetes treated with low-dose cyclosporin Diabetes 39 1264 1272 10.2337/diabetes.39.10.1264 1:STN:280: DyaK3M%2Fgs1yqtg%3D%3D 2210078
28. CR Stiller J Dupre M Gent D Heinrichs MR Jenner PA Keown A Laupacis R Martell NW Rodger BMJ Wolfe J Mahon 1987 Effects of cyclosporin in recent-onset juvenile type 1 diabetes: impact of age and duration of disease J Pediatr 111 1069 1072 10.1016/S0022-3476(87)80058-6 1:STN:280:DyaL1c%2FmtF2jtg%3D%3D 3316581
29. E Rodriguez MA Delucci F Cano S Valdebenito MC Castillo R Villegas 2005 Comparison of cyclosporin concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation Transplant Proc 37 3354 3357 10.1016/j.transproceed.2005.10.004 1:CAS:528: DC%2BD2MXht1aqtrvF 16298594 (Pubitemid 41659886)
30. S Bergan HE Rugstad O Stokke O Bentdal T Froysaker A Bergan 1993 Cyclosporine A monitoring in patients with renal, cardiac, and liver transplants: a comparison between fluorescence polarization immunoassay and two different RIA methods Scand J Clin Lab Invest 53 471 477 10.3109/ 00365519309092542 1:STN:280:DyaK2c%2FitlOksA%3D%3D 8210969
31. G Feutren R Assan G Karsenty H DuRostu J Sirmai L Papoz B Vialettes P Vexiau M Rodier A Lallemand J-F Bach 1986 Cyclosporine increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial Lancet 2 119 123 10.1016/S0140-6736(86)91943-4 1:STN:280:DyaL283lsF2rsw%3D%3D 2873396
32. PF Bougneres JC Carel L Castano C Boitard JP Gardin P Landais J Hors MJ Mihatsch M Paillard JL Chaussain JF Bach 1988 Factors associated with early remission of type 1 diabetes in children treated with cyclosporine N Engl J Med 318 663 670 1:STN:280:DyaL1c7ktlShtw%3D%3D 3125434
33. G Feutren 1988 Functional consequences of risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials Transplant Proc 20 356 366 1:STN:280:DyaL1c3kvFWkuw%3D%3D 3381298
34. MJ Mihatsch D Belghiti SO Bohman K Porter L Dubertret L Fry L Juhlin H Zachariae G Feutren 1990 Kidney biopsies in control or cyclosporin A-treated psoriatic patients Br J Dermatol 122 36 95 100 10.1111/j.1365-2133.1990.tb02888. x (Pubitemid 20176069)
35. PA Miescher H Favre F Chatelanat MJ Mihatsch 1987 Combined steroid-cyclosporin treatment of chronic autoimmune disease Klin Wochenschr 65 727 736 10.1007/BF01736809 1:STN:280:DyaL2szhtlWmsA%3D%3D 3626435 (Pubitemid 17101155)
36. E Svarstad S Helland T Morken L Bostad A Myking BM Iversen J Ofstad 1994 Renal effects of maintenance low-dose cyclosporin A treatment in psoriasis Nephrol Dial Transplant 9 1462 1467 1:STN:280:DyaK2M7hsF2gtA%3D%3D 7816261
37. Anonymous 1987 The DCCT research group. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the diabetes control and complications trial (DCCT) J Clin Endo Metab 65 30 36 10.1210/jcem-65-1-30
38. NA Sherry EB Tsai KC Herold 2005 Natural history of β-cell function in type 1 diabetes Diabetes 54 532 539 10.2337/diabetes.54.suppl-2.S32 (Pubitemid 43343329)
39. R Assan G Feutren J Sirmai C Laborie C Boitard P Vexiau H Du Rostu M Rodier M Figoni P Vague, et al. 1990 Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin Diabetes 27 768 774 10.2337/diabetes.39.7.768
40. J Dupre CR Stiller M Gent A Donner B von Graffenreid G Murphy D Heinrichs MR Jenner PA Keown A Laupacis J Mahon R Martell NW Rodger BW Wolfe 1988 Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset. The Canadian open study of 44 months Transplant Proceed 20 Suppl 4 184 192 1:STN:280:DyaL1c3kvFWnsw%3D%3D
41. HE Wahlstrom R Akimoto D Endres O Kolterman AR Moossa 1992 Recovery and hypersecretion of insulin and reversal of insulin resistance after withdrawal of short-term cyclosporine treatment Transplantation 53 1190 1195 10.1097/00007890-199206000-00004 1:CAS:528:DyaK38XltVCksLw%3D 1604471
42. R Assan J Timsit G Feutren P Bougneres P Czernichow T Hannedouche C Boitard L-H Noel MJ Mihatsch J-F Bach 1994 The kidney in cyclosporin A-treated diabetic patients: a long-term clinicopathological study Clin Neph 41 41 49 1:STN:280:DyaK2c7osFemsA%3D%3D
43. Stiller personal communication
44. BA Buckingham CI Sandborg 2000 A randomized trial of Methotrexate in newly diagnosed patients with type 1 diabetes mellitus Clin Immunol 96 88 90 10.1006/clim.2000.4882 (Pubitemid 30612775)